Q3 INTERIM REPORT July-Sept 2024
Read More
Mentice has received a €1,062,750 EUR order for simulation solutions from a top 20 global MedTech company
Read more
English / Svenska
Investor > Press Releases >
Mentice's CEO Göran Malmberg to present the company's interim report during a live webcast on October 26 at 10:00 CEST

Mentice's CEO Göran Malmberg to present the company's interim report during a live webcast on October 26 at 10:00 CEST

Thursday, October 19, 2023

Mentice AB (STO: MNTC) announces that the company will present its interim report via webcast conference call with the opportunity for interested parties to ask questions to CEO Göran Malmberg.

The presentation of the Q3-2023 interim report for the period July – Sept 2023 will be held on October 26 at 10:00 CEST. Erik Penser's equity analyst, Rikard Engberg, will moderate the live webcast. For more information on how to join, please visit https://investor.mentice.com/.

The presentation will be held in English. Participants are advised to join a few minutes in advance.

For more information, please contact:
Göran Malmberg, CEO, Mentice
E-post: goran.malmberg@mentice.com
US Mobile. +1 (312) 860 5610
Sweden Mobile +46 (0) 703 09 22 22

About Mentice
Mentice (STO: MNTC) is the world leader in proficiency based simulation solutions for image guided interventional therapies. Our solutions help healthcare professionals acquire, retain, and enhance their procedural skills driving improved productivity and outcomes. Mentice solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular, and peripheral interventions are just some of the clinical areas covered by our solutions. Learn more about the features and benefits of Mentice solutions at: www.mentice.com

Marketplace| Nasdaq First North Growth Market, Stockholm | Ticker symbol MNTC
Certified Adviser| FNCA Sweden AB

Attachments
Mentice's CEO Göran Malmberg to present the company's interim report during a live webcast on October 26 at 10:00 CEST

SHARE INFORMATION
The StockTop 10 ShareholdersCertified Advisor
PRESS RELEASES
All2022202120202019
FINANCIAL CALENDAR
Financial Calendar
financial reports
All
2022
2021
2020
2019
2023
2024
2025
CORPORATE GOVERNANCE
Corporate GovernanceArticle of AssociationGeneral MeetingsBoard of DirectorsSenior ManagementAuditorsBoard CommitteesCorporate Share HoldingsGuidelines for RemunerationNomination CommitteeSustainabilityMedia
other
About usContactCompany PresentationBack to Mentice
Data PolicyQuality PolicyDisclaimerTerms
Copyright © 2023 Mentice AB (publ) . All rights reserved.
Q3 DELÅRSRAPPORT Juli-Sept 2024
Läs mer
Mentice får en order på simuleringslösningar värd €1,062,750 EUR från ett topp 20 globalt medtech bolag
Läs Mer
English / Svenska
Investor > Pressmeddelanden >
Mentice's CEO Göran Malmberg to present the company's interim report during a live webcast on October 26 at 10:00 CEST

Mentice's CEO Göran Malmberg to present the company's interim report during a live webcast on October 26 at 10:00 CEST

Thursday, October 19, 2023

Mentice AB (STO: MNTC) announces that the company will present its interim report via webcast conference call with the opportunity for interested parties to ask questions to CEO Göran Malmberg.

The presentation of the Q3-2023 interim report for the period July – Sept 2023 will be held on October 26 at 10:00 CEST. Erik Penser's equity analyst, Rikard Engberg, will moderate the live webcast. For more information on how to join, please visit https://investor.mentice.com/.

The presentation will be held in English. Participants are advised to join a few minutes in advance.

For more information, please contact:
Göran Malmberg, CEO, Mentice
E-post: goran.malmberg@mentice.com
US Mobile. +1 (312) 860 5610
Sweden Mobile +46 (0) 703 09 22 22

About Mentice
Mentice (STO: MNTC) is the world leader in proficiency based simulation solutions for image guided interventional therapies. Our solutions help healthcare professionals acquire, retain, and enhance their procedural skills driving improved productivity and outcomes. Mentice solutions are scientifically validated and have been specifically developed for healthcare providers and the medical device industry. Neurovascular, cardiovascular, and peripheral interventions are just some of the clinical areas covered by our solutions. Learn more about the features and benefits of Mentice solutions at: www.mentice.com

Marketplace| Nasdaq First North Growth Market, Stockholm | Ticker symbol MNTC
Certified Adviser| FNCA Sweden AB

Attachments
Mentice's CEO Göran Malmberg to present the company's interim report during a live webcast on October 26 at 10:00 CEST

AKTIEINFORMATION
AktieinformationTop 10 AktieägareCertifierad RådgivareIncitamentsprogram för anställda
PRESSMEDDELANDEN
Alla2022202120202019
FINASIELL KALENDER
Finansiell kalender
FINANSIELLA RAPPORTER
Alla
2022
2021
2020
2019
2023
2024
BOLAGSSTYRNING
BolagsstyrningBolagsordningBolagsstämmorStyrelseKoncernledningRevisorerStyrelseutskottStyrelsens AktieägandeRiktlinjer för ersättningValberedningHållbarhetMedia
ANNAT
KontaktFöretags PresentationTillbaka till Mentice
Data PolicyQuality PolicyDisclaimerTerms
Copyright © 2022 Mentice AB (publ) . All rights reserved.